Source page: McKinsey & Company

Commentary

Visual form

Table (with Visual Encoding): quarter-by-quarter scenario timeline for US COVID-19 herd immunity.

Layout / body structure

The timeline reads left to right across quarters. Scenario windows are placed from the earliest plausible outcome through the most likely window and then into delayed outcomes on the right.

What is being compared

It compares alternative timing scenarios for US herd immunity under assumptions about vaccine effectiveness, rollout smoothness, cross-immunity, and vaccine safety or efficacy setbacks.

Measurement system

The measure is projected calendar timing by quarter and year. The visual encodes scenario likelihood and timing rather than case counts or death counts.

Visible structure inside the graphic

The central emphasis is on the second half of 2021, with an earlier edge in the second quarter of 2021 and later scenarios extending into 2022 or beyond.

Main takeaway from the visual

The chart shows that the most likely herd-immunity window was the third or fourth quarter of 2021, but that the date could move earlier or later depending on vaccine performance and rollout conditions.

Key standout values or extremes

The earliest plausible window is the second quarter of 2021. The most likely window is the third or fourth quarter of 2021, and the delayed edge reaches 2022 or later.

Controls / sequence, when applicable

This is a static visually encoded scenario timeline; there are no in-chart controls to operate.

Companion media, when applicable

There is no separate companion audio or video; the herd-immunity scenario timeline is the full visual on this page.


US most likely to reach COVID-19 herd immunity in second half of 2021

COVID-19 | Public Health

September 30, 2020 – While the US is most likely to reach COVID-19 herd immunity in the third or fourth quarter of 2021, it could come as early as the second quarter of 2021, if vaccines are highly effective and launched smoothly, or if significant cross-immunity is discovered in a population. But if early vaccine candidates have efficacy or safety issues, the pandemic could extend until 2022 or later.

The probability of reaching COVID-19 herd immunity in the United States is highest in the third or fourth quarter of 2021 but could shift.

To read the article, see “When will the COVID-19 pandemic end?,” September 21, 2020.


customizer here